An old spice with new tricks: Curcumin targets adenoma and colorectal cancer stem-like cells associated with poor survival outcomes
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2025.217885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Sam Khan und 33 weiteren Autor:innen. Beteiligte Einrichtung: Leicester Cancer Research Centre, University of Leicester, Leicester, LE2 9LX, UK. Hauptthemen laut MEDLINE: Curcumin, Colorectal Neoplasms, Neoplastic Stem Cells, Adenoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council, NIHR Leicester Biomedical Research Centre.
Abstract (Originalsprache)
The cost of cancer care globally is unsustainable and strategies to reduce the mounting burden of cancer are urgently needed. One approach is the use of preventive therapies to reduce cancer risk; dietary-derived compounds with good safety profiles represent a promising source of potential candidates but translating encouraging preclinical data to successful trials presents significant challenges. Development of curcumin, from the spice turmeric, as a preventive therapy for colorectal cancer (CRC) is hindered by poor understanding of its mechanism of action. Using patient derived xenografts and ex-vivo 3D-models exposed to clinically achievable curcumin concentrations, we found that it targets proliferating cancer stem-like cells (CSCs) within premalignant adenoma and early-stage cancer tissues, with broad spectrum activity across all molecular subtypes. Transcriptomics analysis revealed that curcumin pushes CSCs towards differentiation over self-renewal, thereby inhibiting tumour development. Evidence suggests these effects involve direct protein binding of curcumin to NANOG, a master regulator of CRC CSCs, and impairment of its transcriptional activity via direct interference with NANOG-DNA binding. Furthermore, curcumin decreased the proportion of proliferating CSCs, defined by NANOG/Ki67 co-expression in patient derived explants and individuals with tumours containing a small fraction of these cells had greatly improved progression-free survival compared to those in the highest quartile for expression. The use of curcumin to minimise this cellular population may yield significant benefit and its clinical evaluation is warranted. Overall, this study provides crucial mechanistic insight, identifying patient populations likely to benefit from curcumin for prevention of sporadic CRC and theragnostic biomarkers for assessing efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leicester Cancer Research Centre, University of Leicester, Leicester, LE2 9LX, UK.
- Genomics Core Laboratory, University of Leicester, Leicester, LE2 7RH, UK.
- University Hospitals of Leicester, Infirmary Square, Leicester, LE1 5WW, UK.
- Leicester Cancer Research Centre, University of Leicester, Leicester, LE2 9LX, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
- Department of Molecular and Cell Biology, University of Leicester, Leicester, LE2 9LZ, UK; School of Molecular and Cellular Biology, University of Leeds, Leeds, LS2 9JT, UK.
- Department of Molecular and Cell Biology, University of Leicester, Leicester, LE2 9LZ, UK; School of Life Sciences, University of Keele, Staffordshire, ST5 5BG, UK.
Förderung
- Cancer Research UK
- Medical Research Council
- NIHR Leicester Biomedical Research Centre
- Wellcome Trust
- National Institute for Health and Care Research
- Leicester Experimental Medicine Centre
- University of Leicester
Zitieren
APA
Khan, S., Karmokar, A., Howells, L., Britton, R. G., Parrott, E., Palacios-Gallego, R., Tufarelli, C., Cai, H., Higgins, J., Sylvius, N., West, K., McGregor, A., Moore, D., Burgess, S. G., Richards, M. W., Winter, A., Sidat, Z., Foreman, N., Hoorn, S. T., …, & Brown, K. (2025). An old spice with new tricks: Curcumin targets adenoma and colorectal cancer stem-like cells associated with poor survival outcomes. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217885
Vancouver
Khan S, Karmokar A, Howells L, Britton RG, Parrott E, Palacios-Gallego R, et al. An old spice with new tricks: Curcumin targets adenoma and colorectal cancer stem-like cells associated with poor survival outcomes. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217885
BibTeX
@article{Khan2025,
author = {Khan, Sam and Karmokar, Ankur and Howells, Lynne and Britton, Robert G and Parrott, Emma and Palacios-Gallego, Raquel and Tufarelli, Cristina and Cai, Hong and Higgins, Jennifer and Sylvius, Nicolas and West, Kevin and McGregor, Angus and Moore, David and Burgess, Selena G and Richards, Mark W and Winter, Anja and Sidat, Zahirah and Foreman, Nalini and Hoorn, Sanne T and Vermeulen, Louis and Singh, Baljit and Hemingway, David and Norwood, Michael and Miller, Andrew and Boyle, Kirsten and Ho, Carmen and Aslam, Muhammad I and Bayliss, Richard and Nateri, Abdolrahman S and Rufini, Alessandro and Gescher, Andreas and Thomas, Anne L and Steward, William P and Brown, Karen},
title = {An old spice with new tricks: Curcumin targets adenoma and colorectal cancer stem-like cells associated with poor survival outcomes},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2025.217885}
}
EUVIMED